Format

Send to

Choose Destination
J Thorac Oncol. 2014 Jul;9(7):e49-50. doi: 10.1097/JTO.0000000000000134.

Detection of EGFR mutations in the plasma of patients with lung adenocarcinoma for real-time monitoring of therapeutic response to tyrosine kinase inhibitors?

Author information

1
*Department of Pneumology, La Roche sur Yon Hospital, La Roche sur Yon, France; and †Department of Biochemistry, Nantes University Hospital, Nantes, France.
PMID:
24926553
PMCID:
PMC4132039
DOI:
10.1097/JTO.0000000000000134
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center